Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Participating in Scottish Stratified Medicine Initiative

NEW YORK (GenomeWeb News) – Life Technologies today announced its participation in the Stratified Medicine Scotland Innovation Centre, or SMS-IC, a collaboration among academic, industrial, and the UK's National Health Service community to create a stratified medicine research infrastructure.

Life Tech is the lead commercial partner in SMS-IC along with biomedical informatics firm Aridhia, and the Ion Proton benchtop sequencer will be used as the primary tool "to drive discovery and genetic analysis."

The goal of SMS-IC is to "prove the principle of stratified clinical trials," and a number of projects will be initiated this year linking patient phenotype, genotype, and other data that enable the targeting of specific populations for clinical trials. Ion Torrent is for research-use only, but Life Tech said that, ultimately, the goal is to progress stratified clinical trial models from concept to clinical use.

In addition, SMS-IC will hold a competition to identify appropriate projects, Life Tech said.

"The vision for this project is to combine an individual's detailed genomic data with more traditional patient information to enable faster, more accurate, and effective clinical decisions," Peter Silvester, president of Europe, Middle East, and Africa of Life Technologies, said in a statement.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.